Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129M
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
23.2M
-
Shares change
-
-10.7M
-
Total reported value, excl. options
-
$25.4M
-
Value change
-
-$11.8M
-
Put/Call ratio
-
0.74
-
Number of buys
-
19
-
Number of sells
-
-48
-
Price
-
$1.09
Significant Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q2 2022
90 filings reported holding ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock as of Q2 2022.
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.2M shares
of 129M outstanding shares and own 17.97% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6.39M shares), BlackRock Inc. (3.59M shares), D. E. Shaw & Co., Inc. (2.28M shares), Laurion Capital Management LP (2.23M shares), RENAISSANCE TECHNOLOGIES LLC (1.99M shares), MILLENNIUM MANAGEMENT LLC (1.53M shares), GEODE CAPITAL MANAGEMENT, LLC (1.22M shares), SABBY MANAGEMENT, LLC (525K shares), Ergoteles LLC (515K shares), and STATE STREET CORP (481K shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.